Intellia Therapeutics Stock Forecast

Stock Price Forecast

The 22 analysts that cover Intellia Therapeutics stock have a consensus rating of "Buy" and an average price target of $20.02, which forecasts a 44.34% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $58.

Price Target: $20.02 (+44.34%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$20.02	$15	$58
Change	-63.95%	+44.34%	+8.15%	+318.17%

Analyst Ratings

The average analyst rating for Intellia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	7	7	7	7	8	8
Buy	4	4	2	2	4	4
Hold	10	10	8	8	7	9
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	1
Total	22	22	18	18	20	23

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $48 → $58	Strong Buy	Maintains	$48 → $58	+318.17%	Apr 28, 2026
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Sell Maintains $8 → $9	Strong Sell	Maintains	$8 → $9	-35.11%	Apr 28, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $11 → $15	Hold	Maintains	$11 → $15	+8.15%	Apr 28, 2026
Silvan Turkcan Citizens	Citizens	Buy Maintains $28 → $30	Buy	Maintains	$28 → $30	+116.29%	Apr 28, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $27 → $30	Strong Buy	Maintains	$27 → $30	+116.29%	Apr 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

64.15M

from 67.67M

-5.20%

from 67.67M

Revenue Next Year

104.41M

from 64.15M

62.75%

from 64.15M

EPS This Year

-3.68

from -3.81

EPS Next Year

-3.13

from -3.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	33.05M	52.12M	36.28M	57.88M	67.67M	64.15M	104.41M
Revenue Growth	-43.01%	57.69%	-30.40%	59.55%	16.92%	-5.20%	62.75%
EPS	-3.78	-6.16	-5.42	-5.25	-3.81	-3.68	-3.13
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	25	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	105.0M	202.7M
Avg	64.2M	104.4M
Low	32.3M	30.7M

Revenue Growth

Revenue Growth	2026	2027
High	55.2%	216.0%
Avg	-5.2%	62.8%
Low	-52.2%	-52.1%

EPS Forecast

EPS	2026	2027
High	-2.04	-1.76
Avg	-3.68	-3.13
Low	-4.71	-4.37

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.